HHS, White House to Convene Experts on Clinical AI Standards
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- HHS and the White House are convening experts on the benchmarking and evaluation of clinical artificial intelligence, with the stated goal of arriving at "a consensus set of principles," per an invitation reviewed by STAT
- The invitation was issued jointly by the White House's Office of Science and Technology Policy, the FDA, and the Office of the National Coordinator for Health Information Technology
- The process is structured as a one-month "sprint" divided into a written phase and a subsequent discussion phase
- The effort specifically targets clinical AI — tools in or approaching medical use — rather than general artificial intelligence policy
Why it matters: The sprint puts three of the federal government's most powerful health-tech bodies — FDA, ONC, and OSTP — into a single consensus process, meaning whatever benchmarking principles emerge could shape how clinical AI is evaluated across regulated medical devices and broader health IT systems.
